Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 720672 ST. LOUIS, MO
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$17,163,427
+$4,180,538 QoQ
Shares Held
1,014,387
+0.2% QoQ
Ownership
0.724%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#29
of 330 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. NTLA ranks #7 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
This page 		1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in NTLA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,163,427 1,014,387
2026-03-31 $12,982,889 1,012,706
2025-12-31 $8,373,204 931,391
2025-09-30 $13,444,970 778,516
2025-06-30 $7,363,618 785,034
2025-03-31 $5,614,495 789,662
2024-12-31 $4,637,891 397,761
2024-09-30 $1,944,234 94,610
2024-06-30 $2,047,948 91,508
2024-03-31 $2,313,370 84,092
2023-12-31 $2,089,265 68,523
2023-09-30 $1,574,327 49,789
2023-06-30 $1,769,933 43,402
2023-03-31 $1,147,356 30,785
2022-12-31 $1,059,085 30,355
2022-09-30 $1,414,948 25,285
2022-06-30 $1,255,542 24,257
2022-03-31 $1,320,340 18,169
2021-12-31 $2,338,077 19,774
2021-09-30 $2,699,499 20,123
2021-06-30 $3,778,330 23,336
2021-03-31 $2,290,236 28,537
2020-12-31 $982,464 18,060